Image
03.05.2023
77% say rising cost of living negatively impacting how they manage the...
77% of people say that the rising cost of living is negatively impacting how they manage their diabetes o...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more